P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000848160.85133.ee |
| _version_ | 1797285888662700032 |
|---|---|
| author | D. Beauvais M. Sourisseau H. Béhal S. Alfandari N. Simon E. Faure I. Yakoub-Agha |
| author_facet | D. Beauvais M. Sourisseau H. Béhal S. Alfandari N. Simon E. Faure I. Yakoub-Agha |
| author_sort | D. Beauvais |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:09:55Z |
| format | Article |
| id | doaj.art-b5ed9b7355fd4a368653063620d10184 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:09:55Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-b5ed9b7355fd4a368653063620d101842024-03-02T07:47:26ZengWileyHemaSphere2572-92412022-06-0161209121010.1097/01.HS9.0000848160.85133.ee202206003-01209P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATIOND. Beauvais0M. Sourisseau1H. Béhal2S. Alfandari3N. Simon4E. Faure5I. Yakoub-Agha61 Centre Hospitalier Regional et Universitaire de Lille1 Centre Hospitalier Regional et Universitaire de Lille1 Centre Hospitalier Regional et Universitaire de Lille3 Centre Hospitalier Gustave Dron, Tourcoing1 Centre Hospitalier Regional et Universitaire de Lille1 Centre Hospitalier Regional et Universitaire de Lille1 Centre Hospitalier Regional et Universitaire de Lillehttp://journals.lww.com/10.1097/01.HS9.0000848160.85133.ee |
| spellingShingle | D. Beauvais M. Sourisseau H. Béhal S. Alfandari N. Simon E. Faure I. Yakoub-Agha P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION HemaSphere |
| title | P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
| title_full | P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
| title_fullStr | P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
| title_full_unstemmed | P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
| title_short | P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
| title_sort | p1324 a risk based strategy for the use of letermovir in cmv positive recipients of allogeneic hematopoietic cell transplantation |
| url | http://journals.lww.com/10.1097/01.HS9.0000848160.85133.ee |
| work_keys_str_mv | AT dbeauvais p1324ariskbasedstrategyfortheuseofletermovirincmvpositiverecipientsofallogeneichematopoieticcelltransplantation AT msourisseau p1324ariskbasedstrategyfortheuseofletermovirincmvpositiverecipientsofallogeneichematopoieticcelltransplantation AT hbehal p1324ariskbasedstrategyfortheuseofletermovirincmvpositiverecipientsofallogeneichematopoieticcelltransplantation AT salfandari p1324ariskbasedstrategyfortheuseofletermovirincmvpositiverecipientsofallogeneichematopoieticcelltransplantation AT nsimon p1324ariskbasedstrategyfortheuseofletermovirincmvpositiverecipientsofallogeneichematopoieticcelltransplantation AT efaure p1324ariskbasedstrategyfortheuseofletermovirincmvpositiverecipientsofallogeneichematopoieticcelltransplantation AT iyakoubagha p1324ariskbasedstrategyfortheuseofletermovirincmvpositiverecipientsofallogeneichematopoieticcelltransplantation |